NHL STRIVE

NHL STRIVE

NHL STRIVE

CME Programming

Community Practice Considerations: Emerging Bispecific Antibodies in NHL

RELEASED DATE: December 13, 2022
EXPIRATION DATE: December 13, 2023

This enduring TeleECHO program is designed to meet the educational needs of community-based medical oncologists, hematologists, nurse practitioners, pharmacists, and other members of the multi-disciplinary oncology care team.

Considerations for Emerging NHL Management: Contemporary Considerations in the Veterans Administration

RELEASED DATE: November 22, 2022
EXPIRATION DATE: November 22, 2023

This enduring program will focus on the treatment and management of Non-Hodgkin’s lymphoma in the Veterans Affairs setting.
This activity is designed to meet the educational needs of health care professionals practicing within the VA system, including medical oncologists, hematologists, nurse practitioners, pharmacists, and other members of the multidisciplinary oncology care team.

This activity is provided by Med Learning Group.
This activity is supported by an independent medical education grant from Regeneron Pharmaceuticals, Inc.
Copyright © 2024 Med Learning Group. Built by Divigner. All Rights Reserved.

Scroll to Top
Home
Clinical Toolkit
Non-Hodgkin’s lymphoma
Pathogenesis
Diagnosis and staging
Treatments
Reading and Resources
Patient Toolkit
What is NHL
Living with NHL?
FAQs
Glossary of FDA approved drugs for NHL
Resources
Can we Talk
Talk to Us
CME Activities
Animations
Can we Talk?
Contact